As of 2025-03-19, the Relative Valuation of Black Diamond Therapeutics Inc (BDTX) is (19.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.68 USD, the upside of Black Diamond Therapeutics Inc based on Relative Valuation is -1268.9%.
The range of the Relative Valuation is (12.24) - (28.61) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 26.7x | 16.5x |
| Forward P/E multiples | 9.3x - 23.2x | 15.4x |
| Fair Price | (12.24) - (28.61) | (19.64) |
| Upside | -828.5% - -1803.2% | -1268.9% |
| Date | P/E |
| 2025-02-28 | -1.63 |
| 2025-02-27 | -1.58 |
| 2025-02-26 | -1.66 |
| 2025-02-25 | -1.65 |
| 2025-02-24 | -1.76 |
| 2025-02-21 | -1.75 |
| 2025-02-20 | -1.85 |
| 2025-02-19 | -1.92 |
| 2025-02-18 | -1.85 |
| 2025-02-14 | -1.92 |
| 2025-02-13 | -1.90 |
| 2025-02-12 | -1.84 |
| 2025-02-11 | -1.77 |
| 2025-02-10 | -1.81 |
| 2025-02-07 | -2.00 |
| 2025-02-06 | -2.05 |
| 2025-02-05 | -2.21 |
| 2025-02-04 | -2.06 |
| 2025-02-03 | -1.99 |
| 2025-01-31 | -2.13 |
| 2025-01-30 | -2.05 |
| 2025-01-29 | -1.98 |
| 2025-01-28 | -2.01 |
| 2025-01-27 | -1.99 |
| 2025-01-24 | -2.01 |
| 2025-01-23 | -2.03 |
| 2025-01-22 | -2.12 |
| 2025-01-21 | -1.82 |
| 2025-01-17 | -1.79 |
| 2025-01-16 | -1.79 |
| 2025-01-15 | -1.71 |
| 2025-01-14 | -1.83 |
| 2025-01-13 | -1.88 |
| 2025-01-10 | -1.57 |
| 2025-01-08 | -1.65 |
| 2025-01-07 | -1.72 |
| 2025-01-06 | -1.73 |
| 2025-01-03 | -1.79 |
| 2025-01-02 | -1.74 |
| 2024-12-31 | -1.74 |
| 2024-12-30 | -1.75 |
| 2024-12-27 | -1.78 |
| 2024-12-26 | -1.87 |
| 2024-12-24 | -1.78 |
| 2024-12-23 | -1.78 |
| 2024-12-20 | -1.80 |
| 2024-12-19 | -1.78 |
| 2024-12-18 | -1.90 |
| 2024-12-17 | -2.03 |
| 2024-12-16 | -2.14 |